{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:53:55Z","timestamp":1790355235228,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82400583"],"award-info":[{"award-number":["82400583"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20240922"],"award-info":[{"award-number":["BK20240922"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07107-9","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T11:03:34Z","timestamp":1759921414000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Mn-Zn ferrite nanoparticles inducing ferroptosis to reverse the resistance in CML cells"],"prefix":"10.1186","volume":"23","author":[{"given":"Miao","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7001-8383","authenticated-orcid":false,"given":"Yuxiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"key":"7107_CR1","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1002\/ajh.26642","volume":"97","author":"E Jabbour","year":"2022","unstructured":"Jabbour E, Kantarjian H. Chronic myeloid leukemia: 2022 update on diagnosis, therapy, and monitoring. Am J Hematol. 2022;97:1236\u201356.","journal-title":"Am J Hematol"},{"key":"7107_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/cells12131703","author":"M Iezza","year":"2023","unstructured":"Iezza M, Cortesi S, Ottaviani E, Mancini M, Venturi C, Monaldi C, et al. Prognosis in chronic myeloid leukemia: baseline factors, dynamic risk assessment and novel insights. Cells. 2023. https:\/\/doi.org\/10.3390\/cells12131703.","journal-title":"Cells"},{"key":"7107_CR3","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1182\/blood-2016-09-696013","volume":"129","author":"TL Holyoake","year":"2017","unstructured":"Holyoake TL, Vetrie D. The chronic myeloid leukemia stem cell: stemming the tide of persistence. Blood. 2017;129:1595\u2013606.","journal-title":"Blood"},{"key":"7107_CR4","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1038\/leu.2016.115","volume":"30","author":"S Saussele","year":"2016","unstructured":"Saussele S, Richter J, Hochhaus A, Mahon FX. The concept of treatment-free remission in chronic myeloid leukemia. Leukemia. 2016;30:1638\u201347.","journal-title":"Leukemia"},{"key":"7107_CR5","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.ccell.2020.03.006","volume":"37","author":"TP Braun","year":"2020","unstructured":"Braun TP, Eide CA, Druker BJ. Response and resistance to BCR-ABL1-targeted therapies. Cancer Cell. 2020;37:530\u201342.","journal-title":"Cancer Cell"},{"key":"7107_CR6","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"XJ Jiang","year":"2021","unstructured":"Jiang XJ, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22:266\u201382.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"7107_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/EXP.20230117","author":"YW Li","year":"2025","unstructured":"Li YW, Duan YX, Li YY, Gu Y, Zhou L, Xiao ZT, et al. Cascade loop of ferroptosis induction and immunotherapy based on metal-phenolic networks for combined therapy of colorectal cancer. Exploration. 2025. https:\/\/doi.org\/10.1002\/EXP.20230117.","journal-title":"Exploration"},{"issue":"1","key":"7107_CR8","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s12943-024-02162-0","volume":"23","author":"CW Zeng","year":"2024","unstructured":"Zeng CW, Nie DR, Wang XF, Zhong SX, Zeng XB, Liu X, et al. Combined targeting of GPX4 and BCR-ABL tyrosine kinase selectively compromises BCR-ABL plus leukemia stem cells. Mol Cancer. 2024;23(1):240.","journal-title":"Mol Cancer"},{"key":"7107_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-024-01002-7","author":"JY Wei","year":"2024","unstructured":"Wei JY, Chai QY, Qin YQ, Li L, Guo CL, Lu ZY, et al. Hyperoside induces ferroptosis in chronic myeloid leukemia cells by targeting NRF2. Mol Med. 2024. https:\/\/doi.org\/10.1186\/s10020-024-01002-7.","journal-title":"Mol Med"},{"key":"7107_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13040461","author":"A Allegra","year":"2024","unstructured":"Allegra A, Mirabile G, Caserta S, Stagno F, Russo S, Pioggia G, et al. Oxidative stress and chronic myeloid leukemia: a balance between ROS-mediated pro- and anti-apoptotic effects of tyrosine kinase inhibitors. Antioxidants. 2024. https:\/\/doi.org\/10.3390\/antiox13040461.","journal-title":"Antioxidants"},{"key":"7107_CR11","doi-asserted-by":"publisher","first-page":"1402669","DOI":"10.3389\/fimmu.2024.1402669","volume":"15","author":"FM Zhong","year":"2024","unstructured":"Zhong FM, Zhang XR, Wang ZH, Li XL, Huang B, Kong GY, et al. The therapeutic and biomarker significance of ferroptosis in chronic myeloid leukemia. Front Immun. 2024;15:1402669.","journal-title":"Front Immun"},{"key":"7107_CR12","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41565-019-0406-1","volume":"14","author":"V Trujillo-Alonso","year":"2019","unstructured":"Trujillo-Alonso V, Pratt EC, Zong HL, Lara-Martinez A, Kaittanis C, Rabie MO, et al. FDA-approved ferumoxytol displays anti-leukaemia efficacy against cells with low ferroportin levels. Nat Nanotechnol. 2019;14:616.","journal-title":"Nat Nanotechnol"},{"issue":"6","key":"7107_CR13","doi-asserted-by":"publisher","first-page":"20230134","DOI":"10.1002\/EXP.20230134","volume":"4","author":"Y Luo","year":"2024","unstructured":"Luo Y, He XJ, Du QY, Xu L, Xu J, Wang JR, et al. Metal-based smart nanosystems in cancer immunotherapy. Exploration. 2024;4(6):20230134.","journal-title":"Exploration"},{"key":"7107_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/nsr\/nwac167","author":"Y Liu","year":"2023","unstructured":"Liu Y, Quan XB, Li J, Huo JW, Li X, Zhao ZP, et al. Liposomes embedded with PEGylated iron oxide nanoparticles enable ferroptosis and combination therapy in cancer. Natl Sci Rev. 2023. https:\/\/doi.org\/10.1093\/nsr\/nwac167.","journal-title":"Natl Sci Rev"},{"key":"7107_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2021.132303","author":"YX Sun","year":"2022","unstructured":"Sun YX, Xu L, Liu X, Shen YD, Zhang Y, Gu N, et al. Coronal relay reactor Fe3O4@CeO2 for accelerating ROS axial conversion through enhanced enzyme-like effect and relay effect. Chem Eng J. 2022. https:\/\/doi.org\/10.1016\/j.cej.2021.132303.","journal-title":"Chem Eng J"},{"key":"7107_CR16","doi-asserted-by":"publisher","first-page":"29536","DOI":"10.1021\/acsami.9b08948","volume":"11","author":"YX Sun","year":"2019","unstructured":"Sun YX, Yan CY, Xie J, Yan D, Hu K, Huang SX, et al. High-performance worm-like Mn-Zn ferrite theranostic nanoagents and the application on tumor theranostics. ACS Appl Mater Interfaces. 2019;11:29536\u201348.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"6","key":"7107_CR17","doi-asserted-by":"publisher","first-page":"e202113619","DOI":"10.1002\/anie.202113619","volume":"61","author":"C Yao","year":"2022","unstructured":"Yao C, Qi HD, Jia XM, Xu YW, Tong ZB, Gu Z, et al. A DNA nanocomplex containing cascade DNAzymes and promoter-like Zn-Mn-ferrite for combined gene\/chemo-dynamic therapy. Angew Chem-Int Edition. 2022;61(6):e202113619.","journal-title":"Angew Chem-Int Edition"},{"key":"7107_CR18","first-page":"117","volume":"10","author":"YX Sun","year":"2022","unstructured":"Sun YX, Liu X, Wang L, Xu L, Liu KL, Xu L, et al. High-performance SOD mimetic enzyme Au@Ce for arresting cell cycle and proliferation of acute myeloid leukemia. Bioact Mater. 2022;10:117\u201330.","journal-title":"Bioact Mater"},{"key":"7107_CR19","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1016\/j.cell.2023.05.003","volume":"186","author":"DG Liang","year":"2023","unstructured":"Liang DG, Feng Y, Zandkarimi F, Wang H, Zhang ZD, Kim J, et al. Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones. Cell. 2023;186:2748.","journal-title":"Cell"},{"key":"7107_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-023-04905-6","author":"TC Karagiannis","year":"2023","unstructured":"Karagiannis TC, Wall M, Ververis K, Pitsillou E, Tortorella SM, Wood PA, et al. Characterization of K562 cells: uncovering novel chromosomes, assessing transferrin receptor expression, and probing pharmacological therapies. Cell Mol Life Sci. 2023. https:\/\/doi.org\/10.1007\/s00018-023-04905-6.","journal-title":"Cell Mol Life Sci"},{"key":"7107_CR21","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/7674565","author":"SH Liu","year":"2021","unstructured":"Liu SH, Wu W, Chen QQ, Zheng ZY, Jiang XD, Xue Y, et al. TXNRD1: a key regulator involved in the ferroptosis of CML cells induced by cysteine depletion in vitro. Oxid Med Cell Longev. 2021. https:\/\/doi.org\/10.1155\/2021\/7674565. (2021).","journal-title":"Oxid Med Cell Longev"},{"key":"7107_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2021.115852","author":"CZ Song","year":"2022","unstructured":"Song CZ, Li DN, Zhang J, Zhao XY. Role of ferroptosis in promoting cardiotoxicity induced by Imatinib Mesylate via down-regulating Nrf2 pathways in vitro and in vivo. Toxicol Appl Pharmacol. 2022. https:\/\/doi.org\/10.1016\/j.taap.2021.115852.","journal-title":"Toxicol Appl Pharmacol"},{"key":"7107_CR23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.22203\/eCM.v048a04","volume":"48","author":"XL Zhu","year":"2024","unstructured":"Zhu XL, Fu QC, Jiang LF, Zheng LM. Iron oxide nanoparticles for diagnosing and treating degenerative orthopaedic diseases: a review. Eur Cells Mater. 2024;48:45\u201365.","journal-title":"Eur Cells Mater"},{"key":"7107_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02909-3","author":"Y Li","year":"2024","unstructured":"Li Y, Chen J, Xia Q, Shang J, He YJ, Li Z, et al. Photothermal Fe3O4 nanoparticles induced immunogenic ferroptosis for synergistic colorectal cancer therapy. J Nanobiotechnol. 2024. https:\/\/doi.org\/10.1186\/s12951-024-02909-3.","journal-title":"J Nanobiotechnol"},{"key":"7107_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28114562","author":"YX Wang","year":"2023","unstructured":"Wang YX, Wu X, Bao XY, Mou XB. Progress in the mechanism of the effect of Fe3O4 nanomaterials on ferroptosis in tumor cells. Molecules. 2023. https:\/\/doi.org\/10.3390\/molecules28114562.","journal-title":"Molecules"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07107-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07107-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07107-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T11:03:35Z","timestamp":1759921415000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-07107-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7107"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07107-9","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]},"assertion":[{"value":"28 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal experimental protocols were approval from the Institutional Animal Care and Use Committee of Yangzhou University (license number 202211010).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1071"}}